Onconetix, Inc. Research And Development Expense

• Onconetix, Inc. showed a decrease of -92.1% in Research And Development Expense from 2023 to 2024.
• This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on June 2, 2025.
• XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 4 years of available data (2021 to 2024), Onconetix, Inc.'s Research And Development Expense has declined by 88.4%.
• Historical annual values: Fiscal year 2024: $154.4 thousand | Fiscal year 2023: $1.95 million | Fiscal year 2022: $4.13 million | Fiscal year 2021: $1.33 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026